| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.40B | -2.8% |
| Cost of Revenue | $2.65B | -4.6% |
| Gross Profit | $756.0M | +4.4% |
| R&D Expense | $112.0M | +3.7% |
| SG&A Expense | $442.0M | +7.0% |
| Operating Income | $259.0M | +7.5% |
| Interest Expense | $99.0M | +76.8% |
| Pre-tax Income | $187.0M | -9.2% |
| Income Tax | $108.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $484.0M | +32.6% |
| Accounts Receivable | $817.0M | -19.7% |
| Inventory | $444.0M | -8.8% |
| Current Assets | $1.84B | -4.5% |
| Total Assets | $3.77B | -6.8% |
| Current Liabilities | $969.0M | -15.6% |
| Long-term Debt | $988.0M | +39.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $308.0M | +23.2% |
| Investing Cash Flow | -$101.0M | +32.7% |
| Financing Cash Flow | -$96.0M | -580.0% |
| +3.8% |
| Net Income | $79.0M | -22.5% |
| EPS (Basic) | $1.80 | -17.1% |
| EPS (Diluted) | $1.76 | -18.9% |
| Total Liabilities |
| $2.19B |
| +1.9% |
| Stockholders' Equity | $1.57B | -16.6% |